RESEARCH & INNOVATION SHOWCASE Dr Lauren Walker MRC Clinical Training Fellow supported by the North West England MRC Fellowship Scheme in Clinical Pharmacology.

Slides:



Advertisements
Similar presentations
The CASA Project IACFS/ME September 23, CASA ME/CFS Patient Data Need a Home! C ollection A ggregation S torage A nalysis.
Advertisements

Mental health strategy of the Medical Research Council (UK) Opportunities for European engagement and a role of FEAM European Parliament 22 nd March 2011.
PERSONALIZED MEDICINE. What is Personalized Medicine? Information-based healthcare –Person-by-person: high content, resolution & fidelity –Ushered in.
NIHR Delivering Better Health Through Training Researchers 19 September 2011 Dr David Cox Deputy Director – Research Faculty.
¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
Certified Medical Coders (CMC) translate clinical data from patient health records and assign appropriate medical codes. Their work is submitted to.
Registries, Databases & Clinical Networks David J Burn Newcastle University.
PRoBaND Parkinson’s Repository of Biosamples and Networked Datasets History Hypotheses Overview Linkage to other studies Funded by Parkinson’s UK Dr Donald.
The Sudden Death in the Young Registry. Screening for Sudden Cardiac Death in the Young Report from a National Heart, Lung, and Blood Institute Working.
Cross-border biomarker research of ovarian cancerCrossBiomark (HUSRB/1203/214/091) The project is co-financed by the European Union
Research & Innovation Horizon societal challenge 1 Open Info Day Funding Opportunities for SMEs Horizon 2020 "Health, demographic change and wellbeing"
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 1 Improvement in Dose Selection: FDA Perspective IDSA/ISAP/FDA Workshop.
Aging Cognition Evaluation A Unique Opportunity in understanding age related disorders.
Turning a clinical question into a testable hypothesis Lauren A. Trepanier, DVM, PhD Diplomate ACVIM, Diplomate ACVCP Department of Medical Sciences School.
Alzheimer’s Society, UK Our research programme
Experimental Cancer Medicine – the future of cancer care Rosie Davies (LECMC RP based at RLUH) Janet Davies (LECMC RP based at CCO)
Indiana Institute For Personalized Medicine David A Flockhart MD, PhD Professor of Medicine, Genetics and Pharmacology Indiana University.
Luu CD, Dimitrov PN, Robman L, et al. Role of flicker perimetry in predicting onset of late-stage age-related macular degeneration. Arch Ophthalmol. 2012;130(6):
Introduction of Department of Molecular Biology for Public Health in SCDC Ye Lu Shanghai Municipal Center for Disease Control & Prevention Shanghai Institute.
 Just one GP agreed with the statement “I think that the consultant should see every patient in person”. Patient survey  All patients referred to teledermatology.
Proposal for End-of-Phase 2A (EOP2A) Meetings Advisory Committee for Pharmaceutical Sciences Clinical Pharmacology Subcommittee November 17-18, 2003 Lawrence.
Presentation/Phenotype
PZP: A novel biomarker for early Alzheimer’s disease ? Diana A.T. Nijholt Department of Neurology Laboratory for Clinical and Cancer Proteomics
Master’s Essay in Epidemiology I P9419 Methods Luisa N. Borrell, DDS, PhD October 25, 2004.
Peter Moore 10/05/051 ANN survival prediction for cancer patients Peter Moore High Energy Physics University of Manchester.
Joe Ma Research Interests: Drug Metabolism/PK and Pain Past: Examined and validated methods to evaluate drug-drug interaction/phenotyping studies (e.g.,
Full Proposal for the German Cancer Aid Priority Program 'Translational Oncology' (2st call) 2015 Lead Applicants: Prof. Dr. med. Magnus von Knebel Doeberitz.
Community Abstract Burnout is a syndrome that has been widely studied and has been of increased interest in the medical field in recent years. It can lead.
Dr Jane Lewis, Clinical Specialist and Research Podiatrist A successful collaboration between Huntleigh and Cardiff NHS Podiatry Department.
Evaluating Community-Based Nutrition Education Programs: The Food Literacy Partners Program Kathryn Kolasa, PhD, RD, LDN Rebecca Rawl, MPH Lauren Whetstone,
Wellcome Trust / Glaxo Smith Kline Translational Medicine Training Programme at Imperial College Dr Waljit Dhillo.
PRESENTAZIONE DEL WORK PROGRAMME 2013 HEALTH Gabriella Balestra BIOLAB - Dipartimento di Elettronica e Telecomunicazioni.
Novel bacterial biomarkers in the early diagnosis of paediatric sepsis Sarah Hopkinson Jonathan Benger Simon Jackson.
Odor-based Sensors for Ovarian Cancer Detection
The CLAHRC Fellowship Dr Christine Hill Deputy Director, Lead for CLAHRC Fellowship. CLAHRC East of England.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Seizure Relapse and Development of Drug Resistance.
Research Problems, Purposes, & Hypotheses
Introduction to Quantitative Research
Student Quality Ambassador Programme
Centre for Clinical Microbiology Meeting
TBCRC (the translational breast cancer research consortium) 005 Prospective study
Dr Charlotte Lemech Medical Director, Scientia Clinical Research
Careers in Medical Research
Patients presenting with clinical features compatible with MAE but with seizure semiology consistent with focal seizure or focal abnormality seen in the.
MANAGEMENT OF HEALTHY SCHOOL ENVIRONMENTS
Proteomic Analysis post Acute Spinal Cord Injury in human
RESEARCH & INNOVATION SHOWCASE Dr Marie M Phelan
South Texas Oral Health Network (STOHN) & the Tooth Fairy Project
Welcome to Wessex Strategic Clinical Networks Transformation Project Workshop 20/09/2018.
COPD by the Guidelines.
RESEARCH & INNOVATION SHOWCASE Dr Jill Madine
Integrating Epilepsy Performance Measures Into Clinical Practice
RESEARCH & INNOVATION SHOWCASE Alan Morgan, Jeff Barclay, Bob Burgoyne (Physiology) Graeme Sills, Tony Marson (Pharmacology/Walton Centre Neurology) Epilepsy.
C. Allison Stewart, Lauren Averett Byers  Cancer Cell 
Comments on design and sequence of biomarker studies
Benjamin Wooden, Nicolas Goossens, Yujin Hoshida, Scott L. Friedman 
Focus of research group – AFib
Improved Patient Outcomes Best Available Clinical Evidence Patient’s
The EMPIR NeuroMET project
Post-registration Training for Pharmacists Fully funded by HEE
REFERENCES AND ACKNOWLEDGEMENTS
My journey into academic general practice
PROSTATE CANCER CIRCULATING BIOMARKER CONSENSUS STATEMENT QUESTIONS
Evaluation.
C. Allison Stewart, Lauren Averett Byers  Cancer Cell 
The Role of the Cardiovascular Nurse Alison de Vries
Vascular Effects of VEGFi Anti-Cancer Drugs
Generating reliable evidence on the determinants of NCDs
Presentation transcript:

RESEARCH & INNOVATION SHOWCASE Dr Lauren Walker MRC Clinical Training Fellow supported by the North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics, funded by the MRC, ICON, GSK, AZ, and the Medical Evaluation Unit. PhD examines the role of HMGB1 in seizures and epilepsy in both experimental models and patients with drug resistant epilepsy Aim is to identify novel, blood biomarkers for early patient stratification in drug-resistant epilepsy Poster B7

RESEARCH & INNOVATION SHOWCASE Dr Lauren Walker Expertise Healthy volunteer study for biomarker validation (circadian variability) Patient study involving blood and CSF sampling Experimental models of seizure and epilepsy Human study involving patients with drug-resistant epilepsy Next steps Examine a biobank of patients with newly diagnosed epilepsy - predictive capability of the the biomarker in resistance and response Future steps Prospective human study collecting blood from all patients with seizures – predictive biomarker of further seizures, epilepsy and drug-resistance Poster B7

RESEARCH & INNOVATION SHOWCASE Dr Lauren Walker What we need help with: Current HMGB1 analysis method (LCMS/MS) is time limiting A reliable, high throughput method is highly sought after Point-of-care test Poster B7